Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V4PH
|
|||
| Former ID |
DIB015233
|
|||
| Drug Name |
Tolerimab
|
|||
| Synonyms |
Transplant rejection therapy, Innogenetics; MAbs (organ transplant), Innogenetics; Monoclonal antibodies (organ transplant), Innogenetics; ToleriMab (anti-B7.1/B7.2)
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Transplant rejection [ICD-11: NE84; ICD-9: 279.5, 996] | Terminated | [1] | |
| Company |
Innogenetics NV
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011393) | |||
| REF 2 | US patent application no. 2004,0171,123, Albumin fusion proteins. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.